Potential role of lipid peroxidation derived DNA damage in human colon carcinogenesis: studies on exocyclic base adducts as stable oxidative stress markers

Molecular pathways to colorectal cancer involve multiple genetic changes that may be caused by overproduction of reactive oxygen species in cancer-related genes. Our aim was to investigate, whether besides direct oxidative DNA damage, reactive oxygen and nitrogen species induce lipid peroxidation (L...

Full description

Saved in:
Bibliographic Details
Main Authors: Bartsch, Helmut (Author) , Nair, Jagadeesan (Author)
Format: Article (Journal)
Language:English
Published: 8 October 2002
In: Cancer detection and prevention
Year: 2002, Volume: 26, Issue: 4, Pages: 308-312
ISSN:1873-443X
DOI:10.1016/S0361-090X(02)00093-4
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/S0361-090X(02)00093-4
Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0361090X02000934
Get full text
Author Notes:Helmut Bartsch, Jagadeesan Nair
Description
Summary:Molecular pathways to colorectal cancer involve multiple genetic changes that may be caused by overproduction of reactive oxygen species in cancer-related genes. Our aim was to investigate, whether besides direct oxidative DNA damage, reactive oxygen and nitrogen species induce lipid peroxidation (LPO) that could yield etheno-DNA adducts via trans-4-hydroxy-2-nonenal, a major aldehyde generated by LPO, in colon tissue. We analyzed the etheno-DNA adducts by a highly specific, ultrasensitive method involving immunoaffinity chromatography coupled with 32P-postlabelling [Carcinogenesis 16 (1995) 613] in affected colon epithelium from ulcerative colitis, Crohn’s disease and familial adenomatous polyposis (FAP) and compared them with asymptomatic colon tissue. In all these cancer prone colon tissues, the formation of markedly enhanced etheno adduct levels was demonstrated for the first time. Etheno-DNA adducts are promutagenic and cause genomic instability that could drive the inflamed colonic epithelia to malignancy. Etheno-DNA adducts appear promising biomarkers for (i) quantifying increased DNA damage in early stages of colon carcinogenesis and for (ii) verifying the efficacy of new antioxidants (e.g. [Lancet Oncol. 1 (2000) 107]) and chemopreventive agents in lowering oxidative stress and related cancer risk.
Item Description:Gesehen am 12.01.2021
Physical Description:Online Resource
ISSN:1873-443X
DOI:10.1016/S0361-090X(02)00093-4